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This paper  outlines  the  capabilities  of pooled  cross-sectional  time  series  methodology  for
the  international  comparison  of  health  system  performance  in population  health.  It shows
how  common  model  speciﬁcations  can  be  improved  so  that  they  not  only  better  address  the
speciﬁc nature  of time  series  data  on  population  health  but are  also more  closely  aligned
with  our  theoretical  expectations  of  the  effect  of healthcare  systems.  Three  methodologicaleywords:
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innovations  for  this  ﬁeld  of  applied  research  are  discussed:  (1)  how  dynamic  models  help  us
understand  the  timing  of  effects,  (2)  how  parameter  heterogeneity  can  be  used  to compare
performance  across  countries,  and  (3)  how  multiple  imputation  can be used  to deal  with
incomplete  data.  We  illustrate  these  methodological  strategies  with  an  analysis  of  infant
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. Introduction
Modern welfare states devote a large share of their
esources to the provision of healthcare services. Consid-
ring that most of healthcare spending comes from public
udgets and could be spent on other important domains
uch as education or national security, there is a natural
nterest in assessing if money on healthcare is well spent.
erformance analysis of healthcare systems seeks to assess
o what extent the healthcare system meets its objectives
1] and therefore, it needs to clearly deﬁne what the key
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objectives are and then develop reliable and valid measure-
ments [1].
A major catalyst for the current debate on the merits
and pitfalls of international performance analysis was the
country ranking put forward by the WHO  in their 2000
World Health Report [2]. This ranking has received strong
criticisms on various aspects of the applied methodology
[3–5]. However, it has both stimulated policy-makers inter-
est in comparative performance analysis and a scientiﬁc
debate on the methodological difﬁculties and requirements
for valid comparisons [6]. The most challenging aspect of
performance analysis clearly is to develop measures whose
variation can be unequivocally attributed to the healthcare
system [7]. The aim of this article is to show how multi-
variate analysis and its advantage of being able to control
for confounding factors can be used in performance anal-
ysis. In particular, we  discuss the capabilities of pooled
cross-sectional time series (PCTS) methods for studying the
Open access under CC BY-NC-ND license.international performance of healthcare systems in popu-
lation health.
Performance analysis can be conducted on different
levels, e.g. on the macro-level (overall system), meso-level
 CC BY-NC-ND license.
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(regions or organizations), or micro-level (individual
patients or providers) [1]. The macro level is sometimes
seen as too abstract and scholars suggest focusing on
micro- and meso-level outcomes [7]. Considering that
macro-level studies are also seen at high risk for ecological
fallacy, this raises the question if we should do whole-
system comparisons after all. We  think that there are a
number of reasons why whole-system comparisons are a
crucial component of healthcare performance analysis.
First, there is a need for information at the system
level [8]. As policymakers and national stakeholders gov-
ern healthcare systems as a whole and are held accountable
to their overall performance, they require comparative
information to determine what is working in their sys-
tem, where there is room for improvement and what are
successful policies in other countries.
Second, evidence from small scale studies is not
sufﬁcient for drawing conclusions on whole system per-
formance. Clinical and experimental studies have high
internal validity which means that we can be fairly cer-
tain that X caused Y. But since they rely on speciﬁcally
deﬁned populations and controlled settings, their results
are not necessarily representative of usual care [9]. Third,
the system-level is often the level where the interesting
variation occurs. Geoffrey Rose [10] famously argued in
the public health literature that clinical studies within a
population can miss important causal factors for disease if
there is minimal variation within the population studied.
The system level is the level where we can assess the effect
of institutions and health policy on outcomes [9] as they
tend to vary more across than within regional or national
systems.
As improving and maintaining population health is
one of the most fundamental goals of healthcare systems,
a signiﬁcant body of work has examined the impact of
healthcare expenditure on health outcomes (for a review
see [11]). There are two prominent approaches for inves-
tigating the effect of healthcare on population health [12].
The avoidable mortality approach relies on a selection of
causes of death that experts deﬁne as avoidable through
the delivery of appropriate healthcare. The idea is then
to assess performance based on how avoidable mortality
varies across countries and over time. The production func-
tion approach deﬁnes population health as a function of
different input factors. The effect of healthcare on health
is studied in a multivariate model controlling for other
factors such as gross domestic product (GDP) or nutri-
tion. Most often these analyses are based on time series
data for a number of countries. In the following contri-
bution, we will show why these pooled cross-sectional
time series studies (PCTS) provide a useful methodology
for whole-system performance analysis and how exist-
ing modeling strategies in this ﬁeld can be improved.
Firstly, a short overview of the existing literature on the
effects of healthcare systems on population health and
their methodological challenges is given. Then, we  present
three strategies which can improve existing analyses in
comparative population health research by simultaneously
addressing the risk of common types of biases and allowing
a better alignment of theoretical expectations and empiri-
cal analysis. This includes a discussion of (1) how dynamic12 (2013) 122– 132 123
models help us understand the timing of effects, (2) how
parameter heterogeneity can be used to assess relative
performance across countries, and (3) how multiple impu-
tation can be used to deal with incomplete data. In the third
part, we  illustrate these strategies with an analysis of infant
mortality rates in 21 OECD countries between 1960 and
2008 using OECD Health Data.
2. Healthcare systems impact on population health
Healthcare systems have various objectives but improv-
ing population health is one of the most important and
thus a measurement of healthcare system performance
would be incomplete without it. The problem is that a
number of other social factors can inﬂuence population
health. Thus scholars have warranted against using pop-
ulation health indicators for performance measurement
since it remains unclear to what extent the healthcare sys-
tem can be held accountable for them [7]. There are two
main approaches for dealing with this issue [12]. One strat-
egy is to select health outcomes that are seen as mainly
affected by healthcare services and create measures for
amenable or avoidable mortality [13]. Comparing countries
and particularly trends of avoidable mortality with overall
or non-avoidable mortality gives us an indication of the
contribution of healthcare systems to population health
[14]. Descriptive comparisons of avoidable mortality trends
are very intuitive but rely on the assumption that we can
clearly distinguish avoidable and non-avoidable causes and
that comparing them sufﬁciently adjusts for confounding
factors. An alternative strategy is the production function
approach which conceptualizes healthcare as one of several
production factors of health [11]. By directly estimating the
effect of healthcare on health within a multivariate frame-
work, this approach is able to control for other social factors
and thereby reduces the risk of confounding.
Being able to control for alternative explanations of
changes in population health patterns is particularly
important because until recently the impact of healthcare
on health has been controversial. For some time there has
been a strong claim that the healthcare system makes only
a small contribution to improvements of population health
[15]. Within the last ten to ﬁfteen years, studies in the area
have proliferated. Reviewing the evidence reveals that the
impact of healthcare depends on the historical time ana-
lyzed and the methods applied.
The historical increase in longevity between the end of
the 18th century and the beginning of the 20th century was
mainly caused by improved nutrition and sanitation rather
than by medical care [16]. However, since 1950 health
care turns out to be one of the most important determi-
nants of rising life expectancy [17]. The results can vary
also with the applied analysis methods. While many of the
early cross-sectional international comparisons came to
the conclusion that there was  no relationship between the
healthcare system and population health [18,19], pooled
time series analysis provided relatively robust evidence
that spending and physician density were associated with
life expectancy increases and mortality decline in high
income countries [11,20–22].
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Within the last decade the number of studies in this area
as increased, data availability has improved, and applied
nalysis methods have become more sophisticated. This
as clearly improved our understanding of the relationship
f healthcare and population health. Nevertheless, there
re at least three major challenges for PCTS analysis of
ealthcare system performance in population health.
First, thanks to international organization such as the
ECD, the WHO, and the UN the availability and qual-
ty of comparative time series data on healthcare inputs
nd health outcomes has substantially improved. Despite
his achievement, time series are far from complete and so
issing data constitute a major challenge for PCTS analysis
or all countries including advanced, industrialized nations.
Second, another important criticism raised against mul-
ivariate analysis of healthcare system performance is that
he models usually assume that the effect of healthcare
n health occurs instantaneously while theoretically we
xpect a time lag between healthcare investments or policy
hanges and health outcomes [14].
Third, pooled models combine information on differ-
nt countries which is useful as it increases efﬁciency
nd allows estimating effects which mainly vary across
ountries. As a result, pooled models provide an average
ffect of healthcare on population health. From a perfor-
ance analysis perspective, researchers might not only
e interested in the average effect but would also like to
nderstand how and why effects differ across countries.
The remainder of this article discusses existing method-
logical strategies to address these challenges which have
arely been used in applied work in this ﬁeld.
. Pooled-cross sectional time series analysis:
ecent developments
PCTS data combine information on different units and
n different points in time. Given that we look at inter-
ational comparison of healthcare systems, we often refer
o the units as countries and the time periods as years,
ut the models discussed can generalize to any PCTS data.
his type of data is most commonly applied in ﬁnancial
nd comparative political economy but also widely used
ithin health economics [20,21,23–26]. PCTS data offer a
ot of advantages for the analyst. Compared to single time
eries studies, PCTS allow analyzing institutional variation
nd other processes that vary across countries. In compar-
son to cross-sectional comparative studies, institutional
nd structural changes can be analyzed and unobserved
ifferences between countries can be statistically adjusted
e.g., as ﬁxed effects). Compared to both alternatives, PCTS
ata contain more units of observation and thus provide
fﬁciency gains and allow including more variables in the
ame analysis model.
There are also drawbacks to PCTS analysis. PCTS
ata come with a speciﬁc error structure that violates
auss–Markov assumptions. First, we usually ﬁnd that
ariables have no constant variance but vary differently
cross countries (cross-section heteroscedasticity). Sec-
nd, countries do not act independently from each other
nd so the value of one country can depend on the values
f other countries (cross-section autocorrelation). Third,12 (2013) 122– 132
due to trends in the data the error term is usually cor-
related between different time points (serial correlation).
These properties of time series data need to be addressed
in the model speciﬁcation. Furthermore, standard regres-
sion models require time series to be stationary which
means that their expected value and population variance
are independent of time and so their mean is the best
long-run prediction. Finally, PCTS analyses are subject to
all standard estimation problems of regression analysis
including heteroscedasticity, omitted variable bias, unob-
served heterogeneity, nonlinear effects, and outliers.
Most analyses within the production of health litera-
ture address serial correlation through generalized least
squares and use ﬁxed effects to adjust for unit hetero-
geneity. Standard regression diagnostics are also widely
applied. Apart from some exceptions, studies in this ﬁeld
fail to discuss the non-stationarity of mortality measures
(see Section 3.1) as well as the heterogeneity of slope
coefﬁcients (see Section 3.2). Finally, missing data receive
little attention in performance analysis and most com-
monly cases with missing values are dropped (see Section
3.3).
3.1. Dynamic models
The question of dynamics addresses the fact that in PCTS
errors usually exhibit serial correlation. Often this was  seen
as “a technical violation of an OLS assumption that leads to
incorrect estimates of the standard errors” (p. 187) [27]. The
proposed solution involved correcting the standard errors
either through feasible generalized least square (GLS) or by
estimating the autocorrelation as a parameter in the model
[28]. However, the underlying reason for serially correlated
errors is that in many applications we  model processes and
so effects occur not instantaneously but over a period of
time. The timing of effects is thus not simply a technical
problem; it is something that researchers are theoretically
interested in [27]. There are many reasons why  we  should
theoretically expect the impact of the healthcare system on
population health to have a time lag. The implementation of
new policies and the system-wide adoption of innovations
take time as it usually requires actors to change established
patterns of behavior. The returns to prevention and invest-
ments in medical technology are spread over longer periods
of times. Ideally our theories would allow a prediction
of the time horizon over which effects unfold. If theories
do not allow such a precise hypothesis, the selection of a
dynamic speciﬁcation should be based on empirical testing.
In general, dynamics are modeled by including lagged val-
ues of dependent and independent variables. A good way
to start is to estimate a general model with a large number
of lags for both the dependent variable and the indepen-
dent variables [29,30]. One can then use test statistics to
assess the number of lags that represent most adequately
the underlying dynamic [29,30]. Unfortunately, there is no
one standard measure for selecting the lag length. It is
therefore recommended to start with a large number of
lags and test down using several statistics such as Adjusted
R2, Bayesian and Akaike information criteria. The aim of
“testing down” is to use the appropriate lag structure but
not more lags than absolutely necessary for a parsimonious
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model. Getting the dynamics right is crucial for valid esti-
mates of coefﬁcients and standard errors [27]. At this point,
most analyses of population health patterns rely on static
models so that it is hard to derive a rule of thumb for the lag
length that should be selected for starting to test down. The
lag length that can be utilized is also restricted by the length
of the time series used as each lag means losing one obser-
vation per country. One should also check the ﬁnal model
for any remaining serial correlation by using a Lagrange
Multiplier test [31].
Serial correlation is an estimation problem that most
PCTS analyses of population health address through
standard error adjustment. However, the fact that the
highly trended nature of mortality time series violates the
assumption of non-stationarity has hardly been acknowl-
edged in the literature (for exceptions, see [32,33]). Using
conventional speciﬁcations for non-stationary (or inte-
grated) time series can lead to spurious regression results
[31].
The generalized error correction model (GECM) [34]
allows estimating short- and long-run effects for non-
stationary time series provided that they are co-integrated
[35].1 Two series are said to be co-integrated if there is a lin-
ear combination of both that is stationary. Practically, this
is the case if the residuals of the regression are stationary.
The error correction model can also be applied to station-
ary series or a mix  of stationary and integrated data [30]. A
bivariate form of the error correction model with one lag is
given by [30]:
Yt = ˛0 − ˛1(Yt−1 − ˇ1Xt−1) + ˇ0Xt + εt
The ﬁrst difference of Y is regressed on the ﬁrst differ-
ence of X, the lag of X, and the lag of Y. In this model a
variable can have a short-term effect (x goes up this year,
y goes up this year) which is given by the differenced term
of the independent variable. It can also have a long-run
effect (x goes up this year, but affects y in future time
periods). X and Y are said to have an equilibrium relation-
ship where changes in x lead to changes in y but over a
longer time period. The lag of the dependent variable meas-
ures the error correction rate that determines the period
after which time X and Y are back into equilibrium after a
shock occurred. The long-run effect is not directly included
as a model parameter but is easily calculated as the ratio of
the lag of X and the lag of Y: k1 = ˇ1/˛1.
Some variables may  only have a short-term effect, e.g.
inﬂuenza immunizations may  only affect inﬂuenza mortal-
ity in the same year. Some indicators may  have a short-term
and a long-run effect, e.g. tetanus immunizations might
reduce associated mortality both in the same year but also
in the longer term. Finally, some measures might exclu-
sively affect outcomes in the long-run, such as the impact
of human papilloma virus vaccinations in teenagers which
will affect deaths from cervical cancer several decades
later. Dynamic models acknowledge that we usually study
processes over time and that causal effects are often not
instantaneous but dispersed over a period of time. An
1 Alternatives include the Engle-Granger two-step error correction
model and models for fractional integration [31].12 (2013) 122– 132 125
error correction model allows for the estimation of both
short- and long-term effects as well as the time it takes
for a change to take full effect. Considering that most
population health series are non-stationary, error correc-
tion models are also warranted to avoid spurious regression
results. Accordingly, one of the ﬁrst steps of PCTS analysis
of population health should be to test if their time series
are non-stationary (and co-integrated).
3.2. Parameter heterogeneity
In a pooled model, we  estimate one coefﬁcient that
gives us an average effect over the countries included in
the sample. For instance, a study aims to assess if patient
cost sharing of services has adverse effects on population
health by looking at the effect of out-of-pocket payments
(OOPs) on mortality. Why  should we  assume that this effect
is the same in all countries? There are many reasons why
this effect could vary across countries – most importantly
the differences in the institutional set-up of cost sharing
in these countries, e.g. the services that cost sharing is
applied to and the exemption rules. If we have a theo-
retical hypothesis for why  an effect should differ across
countries, we can simply estimate an interaction effect with
the institutional system characteristics. Alternatively, one
could estimate the effect of OOPs by country and then com-
pare the coefﬁcients. This is particularly useful when (1)
we do not have a concrete hypothesis why  an effect should
vary across countries, (2) we  do not have measures on our
interacting variables, or (3) we  would like to conduct an
analysis that compares the performance of countries. If we
investigate the performance of healthcare systems based
on resources indicators such as expenditure or provider
density, the country-speciﬁc coefﬁcients can be seen as
a measure of a country’s “relative efﬁciency” [21] in the
production of population health.
In the PCTS literature this is discussed as parameter
heterogeneity. Similarly as dynamic models are a more
theoretically based strategy to address serial correlation,
parameter heterogeneity is a way of directly modeling
cross-section heteroscedasticity in PCTS data instead of
simply adjusting standard errors for it [28]. From an econo-
metric perspective, pooling data has the advantage of
increasing degrees of freedom and so allows introducing
more variables and producing more efﬁcient estimates. As
our theories are usually probabilistic, we aim for evidence
that shows that on average there is a relationship between
x and y, even though it might not exist or be in the oppo-
site direction for individual observations. Following this
notion, a pooled model provides us with an average esti-
mate for all countries and time periods assuming that the
slope coefﬁcients are homogenous. This assumption can be
easily tested and quite often the homogeneity assumption
is rejected. In dynamic models even small deviations from
the homogeneity assumption can create relatively substan-
tial biases [36].
Thus, some authors argue for the use of heterogeneous
estimates [36,37]. The basic idea of heterogeneous esti-
mation is to run separate time series regressions for each
country and then average the individual coefﬁcient esti-
mates (mean group estimator) [37]. Conversely, based on
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vidence from Monte Carlo simulations [38] and a large
umber of case studies [39–41], other scholars argue that
n many cases, due to their simplicity, pooled models
ill produce more adequate predictions even when the
omogeneity assumption is rejected. They can outperform
eterogeneous estimators because of the latters’ parameter
nstability [42]. The stability of the parameters of the
ndividual regressions can be improved by reducing the
umber of regressors in the model but this clearly comes
ith an increased risk for omitted variable bias. Within the
ooled model framework, we can relax the assumption that
ome of the coefﬁcients are homogenous by introducing
nteraction terms between the variable of interest and the
ountry identiﬁer. In a comparative performance analysis
e might be interested in comparing the relative effects of
esources on health across countries but we can also inves-
igate differences in speed as some countries may  show
onger time lags than others. This can be accomplished by
eterogeneous error correction rates.
.3. Multiple imputation
Missing data are a common problem for survey and ofﬁ-
ial data. The most common strategy applied for missing
ata is the exclusion of cases with missing values (list-
ise deletion). Cross-national comparisons of population
ealth rely on comparative datasets provided by interna-
ional organizations such as the World Health Organization
WHO) or the World Bank. Most PCTS analyses of pop-
lation health for advanced, industrialized countries are
ased on the OECD Health Data. While the OECD data are a
igh quality source for international comparison, their time
eries contain a considerable number of missing observa-
ions. Taking two studies using this data as an example
emonstrates how worrisome listwise deletion can be. One
tudy analyzed the impact of the healthcare system on life
xpectancy in 19 OECD countries from 1990 to 2005. The
nalysis samples of the models varied between 59 and 116
bservations which corresponds to 21–41% of all observa-
ions (N = 285) [43]. A second paper studying the role of
edical technology on life expectancy analyzed 25 OECD
ountries between 1960 and 2007 [33]. The number of
bservations used in their models varied between 77 and
37 which correspond to between 6 and 37% of the observa-
ions. The problem with listwise deletion is that it deletes
n observation even if it is only missing on one variable
nd thus throws away all the information available for the
ther variables. A discussion of the role of missingness and
heir potential impact on the results is almost inexistent
n applied work on population health. In addition, to the
eduction in sample sizes as demonstrated, missing data
lso lead analysts to exclude certain analysis periods or
ountries which could have an important impact on the
esults.
An alternative to listwise deletion is multiple imputa-
ion (MI). MI  is a simulation-based (Monte Carlo) approach
hich replaces each missing value through several (m > 1)mputed values [44,46]. Multiple imputation proceeds in
hree steps. First, missing values are imputed based on a
egression model using all variables included in the analy-
is and if needed auxiliary variables. The imputation ends12 (2013) 122– 132
up with m complete datasets. The number of imputations
recommended is usually small: 2–10 for moderate degrees
of missing information [44]. Second, the analysis model,
e.g. a linear regression is estimated with each of the m
datasets. Third, the m parameter estimates and standard
errors are combined into one set. For the combination
of regression estimates one simply takes the average of
the coefﬁcient over the datasets (sum up coefﬁcients and
divide by the number of imputations). For the combination
of the standard errors one has to correct for the sample vari-
ation of the coefﬁcients across the datasets. This is done by
the following rule by Rubin [44] where SE is the imputed
standard error, M the number of imputations, s2
k
the vari-
ance in the kth imputed dataset, bk the coefﬁcient estimate
in the kth dataset, and b the average over the M coefﬁcients
[46].
SE =
√√√√ 1
M
M∑
k=1
S2
k
+
(
1 + 1
M
)  (
1
M − 1
) M∑
k−1
(bk − b)
2
The formula looks more complicated than it is in
practice. Moreover, standard statistical software (STATA,
SAS) provides the combined estimates so that the calcula-
tions usually are not done “by hand”.
Multiple imputation has many advantages. It preserves
all of the existing information in the dataset and increases
efﬁciency [44]. It also requires less restrictive assumptions
about the source of the missingness. Listwise deletion can
be biased when missing data are not completely at ran-
dom which means that missings are neither associated
with observed nor unobserved variables. Multiple imputa-
tion requires the less restrictive assumption that missings
are at random (not associated with unobserved variables)
[46]. Since we never know what causes a speciﬁc missing-
ness pattern, this is an important advantage of multiple
imputation because it reduces potential bias [46]. A study
comparing different ways of treating missing information
in survey data indicates that if less than 10% of the data
were missing, all methods produce similar results [47].
With missing values between 10 and 60% multiple imputa-
tion produces the least biased estimates. When more than
60% of the data are missing, there is no method that can
provide valid results [47]. Data for OECD countries are most
likely to fall into the middle category and so multiple impu-
tation can help reduce potential bias. Low income countries
might face more severe patterns of missing observations.
This does not necessarily preclude the application of mul-
tiple imputation but the risk of bias will remain high and
so even greater care is required in selecting an imputation
model and checking the robustness of results.
Honaker and King [48] developed a multiple imputation
algorithm that is speciﬁcally targeted at PCTS data. It seems
to perform better in producing smooth series over time and
strong shifts between countries – the pattern that we ﬁnd
in PCTS data. They provide an easy-to-use software, Amelia
II, which performs the imputation and allows exporting the
multiple imputed datasets to other software [49].
In summary, missing data are an important issue in the
study of population health that has not been sufﬁciently
acknowledged. Instead of relying on listwise deletion
 Policy 112 (2013) 122– 132 127
+COUNTRYi + εt.
2 To test for the presence of a co-integrating relationship among the
variables used in the analysis the t-statistic on the lagged dependent vari-N. Reibling / Health
which substantially reduces the number of observations,
creates inefﬁciency and potentially bias, multiple imputa-
tion procedures are recommended.
4. Empirical example
The aim of this empirical example is to show how
dynamics, parameter heterogeneity, and multiple impu-
tation can be applied in an analysis of population health
patterns. We  use a model of infant mortality rates in 21
OECD nations from 1960 to 2008 based on the 2010 OECD
Health Data. The countries included are Australia, Austria,
Belgium, Canada, Denmark, Finland, France, Germany,
Greece, Ireland, Italy, Japan, Netherlands, New Zealand,
Norway, Portugal, Spain, Sweden, Switzerland, United
Kingdom, and the United States. In the analysis, we  seek
to explain infant mortality rates through both medical
and non-medical determinants. We  have selected indica-
tors that have commonly been applied in the prediction of
infant mortality [15,19,21]. As medical determinants, we
use total expenditure on population health as % of GDP
(TOTEXP), and the public share of ﬁnancing which is mea-
sured by the % of total health expenditure that comes from
public sources (PUBEXPTOT). Socioeconomic development
is measured by the GDP per capita in purchasing power par-
ities and constant prices. Finally, infant mortality can also
be affected by the health behavior of mothers, in particular
through substance abuse and nutrition. This is operational-
ized via the sugar consumption in kilograms per capita
(SUGAR), and the alcohol consumption in liters per popula-
tion aged 15 and over (ALCOHOL). All variables are included
in log form so that coefﬁcients can be interpreted as con-
stant changes in percentages. Sixty-three percent (652) of
the overall 1029 observations, referring to country-year
points, have no missing values, 16% of the observations
have a missing information on only one variable and 21%
have more missingness. If we just apply listwise deletion,
we reduce the analysis sample by 41%. Deleting an obser-
vation which is missing on only one of the variables would
mean losing information on all the other variables in the
model. If we analyze the missingness patterns further, we
also see that they are not equally spread across countries
and time periods. The largest part of the missings is focused
on the period 1960 and 1969. Some countries, in particular
Belgium, Italy, and Greece have a high number of miss-
ing observations. The missings are thus located at time
points and in countries with higher infant mortality rates.
This selective pattern indicates that the observations are
not missing completely at random and so listwise deletion
could lead to biased results. Instead, multiple imputation
was performed using the Amelia II software [49]. The impu-
tation model contained all analysis variables and additional
variables such as EU and OECD membership which might be
related to the missingness patterns. Diagnostic tests indi-
cate a good ﬁt of the imputation model. For the illustrative
purposes of this example we used only 10 imputations.
The imputed datasets were exported into Stata 12.0 for the
analysis (N = 1029).
The ﬁrst step in the analysis should always be a
visual inspection of the data. We  should ensure that
there is enough variation that makes a statistical modelFig. 1. Infant mortality in 21 OECD countries, 1960–2008, OECD Health
Data  2010 (N = 1024).
meaningful. Within the context of PCTS analysis it is also
important to check if there are trends in the series. Fig. 1
shows infant mortality rates in the 21 OECD countries
using the original dataset without imputations. Infant
mortality rates fell substantially between 1960 and 2008
from an OECD average of 30 deaths per 1000 live births to
3.6. There is also variation across countries in the decline
although overall we ﬁnd a clear sign of convergence.
Portugal was an outlier in the 1960s and 70s with an
infant mortality more than double of the OECD average.
Infant mortality rates are strongly trended in all countries;
the autoregressive coefﬁcient of infant mortality is 0.97.
Accordingly, unit root tests show that infant mortality rates
are clearly non-stationary. The non-stationarity of infant
mortality and other health outcomes has been overlooked
by most studies in the production of health literature with
some exceptions [32,33]. An error correction model is
strongly recommended for such highly trended series in
order to avoid spurious results [29].2
The multivariate analysis is based on a single error cor-
rection models with ﬁxed effects,3 country-speciﬁc linear
time trends and panel-corrected standard errors. The esti-
mating equation then takes the following form:
INFANT = ˛1 + ˇ1 INFANTt−1 + ˇ2 INFANTt−2
+ ˇ3TOTEXP + ˇ4TOTEXPt−1 + ˇ5SUGAR
+ˇ6SUGARt−1 + ˇ7ALCOHOL
+ˇ8ALCOHOLt−1 + ˇ9GDP + ˇ10GDPt−1
+ˇ11PUBLIC + ˇ12PUBLICt−1 + YEARiable was compared with Ericcson and MacKinnon’s critical values [50].
The test is signiﬁcant on the 5%-level which indicates cointegration.
3 In small T analysis, combining ﬁxed effects and lagged dependent vari-
ables contain the risk of Nickell bias. With T > 30, the bias becomes so small
that ﬁxed effects performs as well as more complicated estimators [29].
128 N. Reibling / Health Policy 112 (2013) 122– 132
Table 1
Error-correction estimates of infant mortality rates in 21 OECD nations, 1960–2008.
Model 1 (Pooled) Model 2 (MGE) Model 3 (Pooled)
TOTEXP −0.064* (0.029) −0.075* (0.033) −0.048 (0.030)
TOTEXPt−1 −0.084*** (0.020) −0.103*** (0.027) −0.060* (0.024)
INFMORTt−1 −0.400*** (0.046) −0.427*** (0.063) −0.409*** (0.046)
INFMORTt−2 0.220*** (0.043) 0.157** (0.048) 0.224*** (0.044)
SUGAR 0.056+ (0.032)
SUGARt−1 0.027 (0.027)
ALCOHOL 0.038 (0.030)
ALCOHOLt−1 0.020 (0.021)
GDP  0.029 (0.051)
GDPt−1 −0.020 (0.040)
PUBLIC  −0.074+ (0.043)
PUBLICt−1 −0.087* (0.034)
CONSTANT 8.672*** (2.604) 16.948*** (3.817) 8.014** (2.994)
Long-Run Multiplier and Median Lag
TOTEXP −0.467*** (0.109) −0.382*** (0.114) −0.327** (0.123)
Median Lag 4 2 4
Mean Lag 2 2 2
PUBLIC −0.469* (0.282)
Median Lag 2
Mean Lag 2
N 987 987 987
LM  2(1) 1.552 0.491 2.611
p-value (0.213) (0.484) (0.106)
Note: All variables entered in log form; Fixed effects and country-speciﬁc time trends included but not displayed; N = number of observations;  = ﬁrst
difference; t − 1 = ﬁrst lag; t − 2 = second lag; Panel-corrected standard errors in parentheses. MGE  = mean group estimator; LM 2 = Lagrange multiplier test
for  serial correlation; Standard errors for long-run multipliers are bootstrapped with 1000 replications.
+ p < 0.10.
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the effect has occurred. In our example, health expenditure
has a median lag of 4 years. It can also be very illustrative to
plot how the effect of an increase in expenditure develops
4 The median lag m has to be calculated by hand using the following
formula [33]:
m =
∑R
r=0ωr∑∞
r=0ωr* p < 0.05.
** p < 0.01.
*** p < 0.001.
One of the most important steps in estimating such
 dynamic model is the selection of lag length. We  used
odels with up to ﬁve lags of the independent and depend-
nt variable and compared them based on Adjusted-R2,
kiake’s and Bayesian information criteria. Within this
ecision we should also consider the criterion of parsi-
ony. Thus, if additional lags provide only incremental
mprovements and results are similar, a simple model
hould be preferred. In our case, using one lag for the inde-
endent variables and two lags for the dependent variable
eemed to be the best speciﬁcation of the dynamic process.
 Lagrange multiplier test clearly rejects the null hypothe-
is of independent errors for the model with only one lag.
or the two lag model the test indicates no signiﬁcant serial
orrelation (Table 1).
As we use a dynamic speciﬁcation, heterogeneity in
lope coefﬁcients could bias the results. Thus, in addition to
he pooled model (Model 1), the mean group estimator by
esaran and Smith [37], which estimates country-speciﬁc
ime series regressions and then averages the coefﬁcients,
as applied (Model 2). Both models indicate that total
ealth expenditure signiﬁcantly reduces infant mortality.
he elasticities of the pooled and the averaged model are
elatively similar: a 1% increase in total health expendi-
ure reduces infant mortality in the same year by around
.07% (0.064–0.075%). The total long-run effect on infant
ortality rate is around 0.4% (0.382–0.467%).
In addition to evaluating to what extent the health-
are system has an impact on infant mortality, dynamic
odels allow us to study the timing of the effect: How longdoes it take until investments in healthcare affect infant
mortality? The error correction model includes timing by
distinguishing between short-run and long-run effects. The
long-run effect is given by the long-run multiplier which is
calculated as the ratio of the lagged independent variable
and the error correction rate.
Starting with the pooled model, we  see that an increase
of health expenditure by 1 percent reduces infant mortal-
ity overall by 0.47%. Within the same year of the increase
in spending the reduction is only 0.06%: the rest of the
impact on mortality is dispersed over future years. The
effect declines almost exponentially with a rate of 18%. How
an error correction rate of 18% plays out on the timing of
the effect can be hard to understand for readers. There are
two  ways to illustrate the development of the effect over
time. The median lag4 tells us at which point at least half ofThe numerator is a sum of ω which is the effect a shock in x has at time 0
in  period r. The denominator is the sum over all periods and so is equal to
the long-run multiplier. The r at which m exceeds 0.5 is the median lag.
For an illustration of its calculation, see [33].
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run multipliers for each country were calculated as theFig. 2. Estimated lag distribution of the effect of total health expenditure
on infant mortality.
over time. Fig. 2 shows how a 1% increase in health expen-
diture decreases the infant mortality rate in the 10 years
after expenditure was increased at time 0. While most of
the overall effect occurs in the ﬁrst two to four years, the
impact of expenditure on infant mortality extends a long
time into the future. The mean group estimator model sug-
gests a faster rate of adjustment with a median lag of 2 and
an adjustment rate of 26%. In the ﬁgure, we can see that
for both models a part of the effect still occurs 10 years
after the initial increase in health expenditure. As we  would
have suspected, there is a time lag in the effect of healthcare
spending on infant mortality. Investments that are made at
one point, e.g. in neonatal intensive care units affect infant
mortality not only in the same year but in the long run.
If coverage is extended at one point in time, beneﬁciaries
Fig. 3. Country variation in the effect of health expenditure on infant mortality
multiplier. For the model used to create this graph, please refer to Model 4 in the12 (2013) 122– 132 129
might not only beneﬁt in this year but also in the following
years.
Heterogeneous models are limited in the number of
controls we  can introduce as the individual time-series
regressions have less degrees of freedom. Model 3 thus
examines the effect of total health expenditure controlling
for sugar consumption, alcohol consumption, GDP, and the
public share of ﬁnancing in the pooled framework. Even
after controlling for alternative explanations, healthcare
spending is associated with a reduction in infant mortal-
ity in the long-run. Sugar consumption is associated with a
higher infant mortality in the short-run. Holding the over-
all spending level constant, we  also ﬁnd that a higher share
of public funding results in lower infant mortality rates.
Pooled cross-sectional time-series models provide us
with an average effect of the healthcare system on pop-
ulation health. The inherent interest of a comparative
performance analysis is to assess not only an average effect
across countries but also the relative performance of differ-
ent countries. Assuming homogenous parameter estimates
is a commonly made assumption in pooled cross-sectional
time series. Whether or not the assumption is true can be
tested. In the empirical example, the F-Test rejects the null
hypothesis that all countries have the same long-run effect
of health expenditure. Instead of abandoning the pooled
model and looking at individual time-series regressions,
we can relax the homogeneity assumption by using interac-
tions of health expenditure and the country dummies (see
model 4 in online appendix). Based on this model long-ratio of the lagged expenditure effect and the lagged infant
mortality coefﬁcients. As the long-run multiplier is a ratio,
bootstrapping was  used to derive the conﬁdence intervals.
. Lines represent 90% bootstrapped conﬁdence intervals of the long-run
 online appendix.
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iig. 4. Variation in timing of expenditure effect in selected countries
ased on model with heterogenous long-run effects and error correction
ates (see online appendix Model 5).
ig. 3 plots the long-run multipliers with 90% conﬁdence
ntervals based on 1000 bootstraps.
Despite large conﬁdence intervals and considerable
verlap, we can clearly identify a high-performing group of
ountries where increases in health expenditure have been
ssociated with stronger declines in infant mortality. These
re Switzerland, Japan, Austria, Australia, and France, with
lasticities between −0.6 and −2.1. Most of the countries
ave slope coefﬁcients close to the overall average (−0.5 to
0.25) showing a relatively similar level of performance.
Finally, we may  not want to assume that countries have
he same speed of adjustment by including interactions
f country indicators and the lagged dependent variable.
ig. 4 plots the effect of total healthcare spending on infant
ortality for four example countries: Australia, Denmark,
he Netherlands, and Spain. The countries differ not only in
heir effect of healthcare spending on infant mortality but
lso in the time it takes to achieve the mortality reduction
ith error correction rates varying between 11 and 54%.
. Discussion
PCTS models are a useful tool for performance analy-
is as they allow studying the effect of healthcare systems
n health while controlling for alternative explanations
or population health. Due to the error structure of PCTS
ata, results can be especially sensitive to the chosen
peciﬁcation. For this reason it is crucial to conduct sen-
itivity tests and robustness checks: A RESET test indicates
o omitted variable bias. We  ﬁnd heteroscedasticity and
ontemporaneously correlated errors across panels and
herefore use panel-corrected standard errors. As indicated
efore, the results were similar when more lags were used.
here was no indication for nonlinear effects of the inde-
endent variables. The variance-inﬂation factor indicates
wo multi-collinearity issues. First, the two lags of infant
ortality are naturally highly collinear. However, consid-
ring the lag comparison and the Lagrange–Multiplier
est, omitting the second lag contains a high risk of mis-
pecifying the dynamic. As the resulting serial correlation
s much more severe than the increase in standard errors
nduced through multi-collinearity, the two lag dynamic
s kept [31]. Secondly, introducing country-speciﬁc slope12 (2013) 122– 132
coefﬁcients increases multi-collinearity but the coefﬁcient
estimates are similar to the estimates from country-speciﬁc
regressions. As conﬁdence intervals are bootstrapped, the
inﬂuence of the multi-collinearity on the results should be
minor. Finally, we checked for inﬂuential cases by exclud-
ing one country and one time period at a time.
Model speciﬁcations need to be tailored to the the-
oretical question and the available data at hand. This
article focused on population health analyses in advanced,
industrialized countries where data on several decades are
available. International comparisons including low income
countries face a more challenging data situation (e.g. [51]).
With short time series (T < 15) one might not want to esti-
mate a dynamic model where lagged parameters lead to
additional data loss. As we theoretically assume that many
policy changes take some time to show effects, simply
going back to static models is also problematic. Alternative
strategies that can be applied in this case are a comparison
of cross-sectional models where the independent variables
are lagged at different time intervals or using long-term
differences as independent variables (e.g. 5 year change in
health expenditure).
6. Conclusion
Whole system comparison is an integral part of perfor-
mance analysis in health policy research. Policymakers and
other stakeholders in the system require information on
aggregate performance for making evidence-based health
policy decisions. Alongside improvements in data avail-
ability and quality from international organization such as
OECD and WHO, we have observed an increase in studies
evaluating the impact of healthcare resources and institu-
tional characteristics on population health outcomes. This
body of research has demonstrated the important role of
healthcare resources in longevity gains in advanced, indus-
trialized countries in the second half of the 20th century.
Within the production function approach, empirical anal-
yses of population health have shown the usefulness of a
multivariate framework in determining the performance of
healthcare systems. While this is an important advantage
for different outcomes of performance (e.g. cost, quality),
[52,53] it is particularly important in the context of popu-
lation health.
This article has identiﬁed three challenges of PCTS anal-
ysis in this ﬁeld of research and outlined strategies on
how to improve model speciﬁcations to make them both
methodologically more adequate and more closely aligned
with theoretical expectations. First, time-series data on
population health and healthcare system characteristics
usually contain a high degree of missing information.
We have outlined how multiple imputation can be used
rather than listwise deletion to preserve information and
avoid bias when missingness is not completely at ran-
dom. Secondly, investments in healthcare resources and
structural reforms take time to affect population health
outcomes. Dynamic speciﬁcations such as error correc-
tion models allow estimating the timing of effects. As
policymakers think in electoral cycles, they are equally
interested in the overall effect of policy changes as they
are in the time it takes for them to take effect. Dynamic
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models thus extend performance analysis by the often
overlooked dimension of time. In addition, error correc-
tion models can help avoid spurious regression results in
the context of the non-stationarity of most measures used.
Third and ﬁnally, most pooled analyses focus on average
effects of healthcare resources and health policy meas-
ures. From the perspective of performance analysis, we
are also interested in the relative performance of different
countries. PCTS analysis allows comparing effects across
countries by relaxing the assumption of homogenous slope
coefﬁcients.
Using an empirical example of infant mortality rates in
the OECD countries, we illustrated these three strategies
and showed how dynamic speciﬁcations and parameter
heterogeneity provide more informative results for health
policymakers. While PCTS analysis often seems complex
and technical, we have shown how quantities such as
median lags and graphs make the results accessible to read-
ers without the background knowledge of econometrics.
While we have argued throughout the article for the
capabilities of PCTS analysis, it is important to also point out
its limitations. PCTS analysis provides average effects on
performance over certain time periods. This average effect
might not necessarily provide good forecasts for future
periods or speciﬁc nations. While PCTS allows controlling
for alternative explanations, the availability of time series
data is limited, e.g. by the lack of quality of life data, institu-
tional indicators. PCTS analysis can also be quite sensitive
to speciﬁcation decisions. Dynamic models and parame-
ter heterogeneity are powerful tools in PCTS analysis but
they are not always appropriate for the research question
and data at hand. Theory and speciﬁcation tests should
guide the model selection for applied researchers in order
to provide robust results. In addition, one may  want to
compare the results of different model speciﬁcations and
outline differences in conclusions drawn from them as we
did in the empirical example.
Considering how tricky the analysis of healthcare per-
formance is, PCTS can only be one among a variety of
methodologies including the analysis of avoidable mor-
tality trends [13], composite indices and scorecards [54],
or data envelopment analysis [55] Yet, to this point we
have not tapped the full potential of PCTS analysis for the
assessment of international performance of healthcare sys-
tems in population health. We  showed three strategies that
can help to improve reliability and validity of results and
extend the policy-relevant information that we can extract
from multivariate analysis of population health.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.
healthpol.2013.05.023.
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